Neonatal Sepsis
Conditions
Brief summary
Breast milk contains many microorganisms including bacteria that are beneficial to health (probiotics), but also bacteria that are generally considered pathogenic. Several studies have described an increased risk of infections due to pathogenic germs in breast milk in premature newborns whose digestive system is immature and whose digestive flora is modified by repeated antibiotic treatments. However, a breastfed baby is better protected against infectious diseases than a bottle-fed baby. The objective of this study is to define the breast milk microbiota of infants with confirmed early or late neonatal bacterial infection compared to the breast milk microbiota of infants with no evidence of bacterial infection. For that purpose, an exploration will be performed using the principle of Microbial Culturomics and targeted metagenomics (16S ribosomal RNA gene sequencing).
Interventions
Collection of breast milk through a sterilized breastfeeding device. Once the collection is completed, the milk will be transferred to a sterile jar provided in a dedicated survey package for transport to the laboratory.
Sponsors
Study design
Eligibility
Inclusion criteria
Breastfeeding mothers of infants: * Aged 1 to 89 days consulting in hospitals in the Marseille area (Assistance Publique des Hôpitaux de Marseille: Hôpital de la Timone-enfants and Hôpital Nord), * Suspected neonatal bacterial infection due to the presence of fever (rectal or axillary temperature \> 38°C), * In whom bacteriological samples have been taken (cerebrospinal fluid, joint fluid, blood cultures, urine), * Patients affiliated or benefiting from a social security system.
Exclusion criteria
* Exclusive formula milk feeding * Opposition of legal guardians * No bacteriological sample to prove infant infection * No confirmation of fever by standardized method * Opposition to participating in the study * Neonatal hospitalization \> 48 hours for management of prematurity. * Severe congenital malformations in the infant. * Antibiotic treatment for a concomitant bacterial infection in the infant.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Description of bacterial carriage of breast milk | 18 months | Identify the bacterial carriage of breast milk of infants with neonatal sepsis. Microbial anlaysis of mother's milk from baby with neonatal sepsis. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Comparison of breast milk of infants with neonatal sepsis to infants without neonatal sepsis. | 18 months | Compare the bacterial carriage (type of germs found) of the breast milk of infants with neonatal sepsis to breast milk of infants with fever for another cause (virus, non identified germ) |
| Comparison of milk germs to children's germs. | 18 months | Compare the germs found in the breast milk of each mother-infant pair with a bacterial infection with the germs identified in the infant. |
| Comparison of microbiota profiles in breast milk | 18 months | Compare the bacterial composition of the breast milk of mother-infant pairs with the same germ (germ infecting the child identical to the germ identified in the mother's milk) versus mother-infant pairs with a different germ in the milk (no germ found in the child when a germ was identified in the breast milk, or germ infecting the child different from the germ identified in the mother's milk). |
Countries
France